Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.12% saline----1件: 299
20.9% Isotonic Saline (IS)----1件: 299
30.9% Isotonic Saline (IS), 4mL----1件: 299
40.9% normal saline (control)----1件: 299
50.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
6033841----1件: 299
71,5 (Butylimino)-1,5-dideoxy-D-glucitol1件: Sorbitol1件: D00096 --1件: 299
81-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299
9100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299
10100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299
11100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299
12100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299
13100 mg TEZ/150 mg IVA FDC----1件: 299
14100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299
15100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299
16100 mg/m2 dose----1件: 299
17100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
18100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
19100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299
20100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299
21100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299
22100-mg VX-445 /50-mg TEZ/75-mg----1件: 299
23100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299
24100g ELX / 50mg TEZ / 75mg IVA----1件: 299
25100mg ELX/50mg TEZ /75mg IVA----1件: 299
26100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299
27150-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
28150mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
292% Chlorhexidine solution wipes1件: Chlorhexidine1件: D07668 --1件: 299
302,3-dihydroxybutanedioic acid----1件: 299
312-aminoethanethiol1件: Cysteamine1件: D03634 --2件: 19, 299
32200 mg/m2 dose----1件: 299
3325-Hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
342622U90 Duramycin1件: Lancovutide---1件: 299
35291844----2件: 246, 299
364% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine1件: D07668 --1件: 299
374-phenylbutyrate1件: Phenylbutyric acid---2件: 251, 299
384.2% NaCl/Inhalation solution----1件: 299
394D-710----1件: 299
405-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 299
4150 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299
4250 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299
435000 IU of cholecalciferol1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
44552-02----2件: 53, 299
456% Hypertonic Saline (HS), 4mL----1件: 299
467% Hypertonic Saline (HS)----1件: 299
477% NaCl----1件: 299
487% saline----1件: 299
4975-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
5080mg ELX / 40mg TEZ / 60mg IVA----1件: 299
51A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299
52AAC Hexal----1件: 299
53ABBV-119----1件: 299
54ABBV-2222----1件: 299
55ABBV-3067----1件: 299
56ABBV-576----1件: 299
57ABELCET1件: Amphotericin B1件: D00203 --1件: 299
58ACC----1件: 299
59ACC600Tabs----1件: 299
60Acebilustat1件: Acebilustat---1件: 299
61Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
62Acetylcysteine1件: Acetylcysteine1件: D00221 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
63ACETYLCYSTEINE SODIUM1件: Acetylcysteine1件: D00221 --1件: 299
64ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299
65Active Treatment Group 7% Hypertonic Saline----1件: 299
66Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299
67Actrapid Penfill 100UI/ml----1件: 299
68Ad26.COV2-S.02----1件: 299
69Ad5-CB-CFTR----1件: 299
70Adempas1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299
71Adempas 0.125 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299
72Adempas 0.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
73Adempas 1.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
74Adempas 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
75Adeno-associated virus-CFTR vector----1件: 299
76Adrenalina----1件: 299
77Adrulipase----1件: 299
78Advagraf prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
79AER002----1件: 299
80Aeroquin----1件: 299
81Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299
82Aerosoltherapy----1件: 299
83AeroVanc----1件: 299
84AIR DNase----1件: 299
85AIR DNase™----1件: 299
86Ajulemic acid1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
87Alanine1件: Alanine1件: D00012 --4件: 6, 13, 298, 299
88Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299
89Alendronate1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 19, 41, 46, 50, 271, 274, 299
90Alendronate sodium1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 19, 299
91Alginate1件: Alginic acid1件: D02324 --2件: 53, 299
92Alginate oligosaccharide1件: Alginic acid1件: D02324 --1件: 299
93Allo-hMSCs----2件: 211, 299
94Alpha-1 HC 100 mg----1件: 299
95Alpha-1 HC 200 mg----1件: 299
96Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299
97Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299
98ALTU-1351件: ALTU-135---1件: 299
99ALTUS-135----1件: 299
100ALX-009----1件: 299
101AMIKACIN1件: Amikacin1件: D02543 --2件: 60, 299
102Amikacin nebulization1件: Amikacin1件: D02543 --1件: 299
103AMIKACIN SULFATE2件: Amikacin,
Sulfate ion		1件: D02543 --1件: 299
104Amikacina1件: Amikacin1件: D02543 --1件: 299
105Amikacina liposomal (Arikace?)1件: Amikacin1件: D02543 --1件: 299
106Amikacine1件: Amikacin1件: D02543 --1件: 299
107Amikacine nebulization1件: Amikacin1件: D02543 --1件: 299
108Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin1件: D02543 --1件: 299
109Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin1件: D02543 --1件: 299
110AMILASA----1件: 299
111Amiloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
112Amiloride HCl1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
113Amiloride Solution for Inhalation1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
114Aminoglycoside----1件: 299
115Amitriptylin1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
116Amitriptylin-CT1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
117Amitriptylin-ct Tabletten1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
118Amitriptyline1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 78, 97, 226, 299
119Amoxicillin1件: Amoxicillin2件: D00229 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
120Amoxicillin and Clavulanic acid1件: Clavulanic acid1件: D07711 --1件: 299
121Amphotericin----1件: 299
122Amphotericin B1件: Amphotericin B1件: D00203 --1件: 299
123AMYLASE----1件: 299
124Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
125Andecaliximab----4件: 46, 96, 97, 299
126Anti-pseudomonas IgY gargle----1件: 299
127Anti-reflux pharmacotherapy----1件: 299
128Antibiotic----1件: 299
129Antioxidant Cocktail----1件: 299
130Antistaminici H1 - H2----1件: 299
131AP----4件: 2, 6, 13, 299
132AP-PA02----1件: 299
133API----2件: 231, 299
134AquADEK----1件: 299
135AquADEKs-2----1件: 299
136ARCT-032----1件: 299
137ARD-3150----1件: 299
138Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
139Aridol1件: Mannitol1件: D00062 --1件: 299
140Aridol or Osmohale1件: Mannitol1件: D00062 --1件: 299
141ARIKACE™----1件: 299
142Arikayce1件: Amikacin1件: D02543 --1件: 299
143Arikayce™1件: Amikacin1件: D02543 --1件: 299
144Arikayce™ 140 mg1件: Amikacin1件: D02543 --1件: 299
145Arikayce™ 560 mg1件: Amikacin1件: D02543 --1件: 299
146Arikayce™ 70 mg1件: Amikacin1件: D02543 --1件: 299
147ARINA-1----2件: 228, 299
148ARO-ENaC----1件: 299
149Asthma patients----1件: 299
150ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
151Ataluren (PTC124®)1件: Ataluren1件: D09323 --1件: 299
152Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
153Atropina1件: Atropine1件: D00113 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
154Augmentin1件: Clavulanic acid1件: D07711 --1件: 299
155Aurexis----1件: 299
156Aurexis® (tefibazumab)1件: Tefibazumab1件: D06054 --1件: 299
157Avian polyclonal IgY antibody against PA----1件: 299
158Avibactam1件: Avibactam---1件: 299
159AZD1236----1件: 299
160AZD5634----1件: 299
161AZD5634 for infusion----1件: 299
162AZD5634 for inhalation----1件: 299
163AZD7986----2件: 44, 299
164AZD9668----1件: 299
165Azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
166Azithromycin 250 mg tablets1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
167Azithromycin 500 mg film-coated tablet1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
168AZITHROMYCIN DIHYDRATE1件: Azithromycin2件: D06390 ,
D07486 		--2件: 228, 299
169AZLI----1件: 299
170AZLI 75 mg three times a day (TID)----1件: 299
171AZLI 75 mg three times daily (TID)----1件: 299
172AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299
173AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299
174Aztreonam1件: Aztreonam1件: D00240 --2件: 228, 299
175Aztreonam for Inhalation (AI)1件: Aztreonam1件: D00240 --1件: 299
176Aztreonam for Inhalation Solution1件: Aztreonam1件: D00240 --1件: 299
177Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam1件: D00240 --1件: 299
178AZTREONAM LYSINE2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
179Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
180Aztreonam solución para inhalación1件: Aztreonam1件: D00240 --1件: 299
181Aztreonan lysine1件: Lysine1件: D02304 --1件: 299
182Bactrim1件: Trimethoprim1件: D00145 --1件: 299
183BAY 85-8501----1件: 299
184BAY q 3939----1件: 299
185BAY63-2521----3件: 51, 86, 299
186BAY85-8501----1件: 299
187BAYQ3939----1件: 299
188BCG----1件: 299
189BCG TICE Vaccine----1件: 299
190Benralizumab1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
191Beta-Adrenergic cocktail----1件: 299
192Beta-lactam antibiotic----1件: 299
193Bethkis----1件: 299
194BH4----5件: 51, 86, 124, 240, 299
195BH4 20mg----1件: 299
196BH4 5mg----1件: 299
197BI 1265162----1件: 299
198BI 1265162 10 µg----1件: 299
199BI 1265162 100 µg----1件: 299
200BI 1265162 25 µg----1件: 299
201BI 1265162 50 µg----1件: 299
202BI 443651----1件: 299
203Biaxin ( clarithromycin)1件: Clarithromycin1件: D00276 --1件: 299
204BIIL 283 BS (Amelubent)----1件: 299
205BIIL 284 BS, high dose----1件: 299
206BIIL 284 BS, high dose, adult patients----1件: 299
207BIIL 284 BS, high dose, pediatric patients----1件: 299
208BIIL 284 BS, low dose----1件: 299
209BIIL 284 BS, low dose, adult patients----1件: 299
210BIIL 284 BS, low dose, pediatric patients----1件: 299
211BIIL 284 BS, medium dose, adult patients----1件: 299
212BIIL 284 BS, medium dose, pediatric patients----1件: 299
213Biklin----1件: 299
214Bio-25 probiotic----1件: 299
215Bisphosphonate treatment----2件: 113, 299
216BLF----1件: 299
217Blood or Saliva Sample Collection----1件: 299
218Blood sample----20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
219Blood test----6件: 36, 51, 107, 113, 162, 299
220Boost VHC----1件: 299
221Boots High Strength Garlic Odour Controlled1件: Garlic1件: D12020 --1件: 299
222BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----1件: 299
223Bramitob----1件: 299
224BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----1件: 299
225Bramitob 300mg/4ml Nebuliser Solution----1件: 299
226BRAMITOB*NEBUL 28F 300MG/4ML----1件: 299
227BRAMITOB*NEBUL 56F 300MG/4ML----1件: 299
228Bramitob® administered by PARI eFlow® rapid electronic nebulizer----1件: 299
229Bramitob® administered by PARI LC® PLUS nebulizer----1件: 299
230Brensocatib1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
231Brensocatib 10 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
232Brensocatib 25 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
233Broccoli1件: Broccoli---3件: 36, 97, 299
234Broccoli sprouts1件: Broccoli---1件: 299
235Bronchial mucus collection----1件: 299
236Bronchitol1件: Mannitol1件: D00062 --1件: 299
237Bucelipase alfa1件: Bucelipase alfa---1件: 299
238BUDESONIDE1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
239Budesonide-formoterol single inhaler2件: Budesonide,
Formoterol		2件: D00246 ,
D07990 		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
240Burlulipase1件: Burlulipase---1件: 299
241C01CA04 - Dopamina1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
242Calcium1件: Calcium---27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299
243Calcium carbonate2件: Calcium,
Carbonate ion		---8件: 13, 19, 46, 53, 75, 96, 235, 299
244Calfactant1件: Calfactant1件: D03317 --1件: 299
245Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
246Cavosonstat1件: Cavosonstat1件: D10916 --1件: 299
247Cayston1件: Aztreonam1件: D00240 --1件: 299
248Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler1件: Aztreonam1件: D00240 --1件: 299
249CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam1件: D00240 --1件: 299
250CB-280----1件: 299
251CEFALEXIN1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
252Cefepime1件: Cefepime1件: D02376 --2件: 60, 299
253Cefiderocol1件: Cefiderocol1件: D11302 --1件: 299
254Ceftaroline1件: Ceftaroline fosamil1件: D08884 --1件: 299
255Ceftazidim1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
256Ceftazidim Fresenius Kabi1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
257Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
258Ceftazidima1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
259CEFTAZIDIMA PENTAIDRATO1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
260CEFTAZIDIME1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
261Ceftazidime and tobramycin2件: Ceftazidime,
Tobramycin		3件: D00063 ,
D00921 ,
D07654 		--1件: 299
262CEFTAZIDIME PENTAHYDRATE1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
263Ceftazidime/avibactam2件: Avibactam,
Ceftazidime		2件: D00921 ,
D07654 		--1件: 299
264Ceftolozane1件: Ceftolozane1件: D10097 --1件: 299
265Ceftolozane/Tazobactam2件: Ceftolozane,
Tazobactam		2件: D00660 ,
D10097 		--1件: 299
266Cefuroxim1件: Cefuroxime1件: D00262 --1件: 299
267Cefuroxime1件: Cefuroxime1件: D00262 --2件: 97, 299
268Cephalexin1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
269CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
270CFTR Modulators----1件: 299
271CFTR potentiator----1件: 299
272ChAdOx1 nCoV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
273CHF 6333----1件: 299
274CHF6333 (Part 1 - SAD)----1件: 299
275CHF6333 (Part 2 - MAD)----1件: 299
276Chlorhexidine1件: Chlorhexidine1件: D07668 --2件: 86, 299
277Chlorhexidine Gluconate1件: Chlorhexidine1件: D07668 --1件: 299
278Chlorhexidine gluconate oral rinse1件: Chlorhexidine1件: D07668 --1件: 299
279Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
280CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299
281Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299
282Cholecalciferol (vitaminD3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
283Cholecalciferol Pill1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
284Choline1件: Choline1件: D07690 --4件: 93, 171, 193, 299
285Choline Chloride2件: Chloride ion,
Choline		1件: D07690 --1件: 299
286Choline supplementation1件: Choline1件: D07690 --1件: 299
287CILASTATIN1件: Cilastatin1件: D07698 1件: DPEP1 💬-2件: 60, 299
288Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
289Cipro Inhale1件: Ciprofloxacin1件: D00186 --1件: 299
290Ciprofloxacin1件: Ciprofloxacin1件: D00186 --5件: 2, 60, 96, 97, 299
291Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
292Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
293Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
294Ciprofloxacin (ciproxin)1件: Ciprofloxacin1件: D00186 --1件: 299
295Ciprofloxacin dispersion for inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
296Ciprofloxacin DPI1件: Ciprofloxacin1件: D00186 --1件: 299
297Ciprofloxacin DPI (BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
298Ciprofloxacin for Inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
299Ciprofloxacin hydrochloride1件: Ciprofloxacin1件: D00186 --2件: 96, 299
300CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE1件: Ciprofloxacin1件: D00186 --1件: 299
301Ciprofloxacin Inhale1件: Ciprofloxacin1件: D00186 --1件: 299
302Ciprofloxacina----1件: 299
303CIPROFLOXACINA CLORIDRATO----1件: 299
304Ciproxin----1件: 299
305CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299
306Ciproxin Suspension----1件: 299
307CIPROXIN*6CPR RIV 500MG----1件: 299
308Clarithromycin1件: Clarithromycin1件: D00276 --8件: 6, 63, 84, 96, 97, 222, 228, 299
309Claritromycin----1件: 299
310Claritromycin 500mg film coated tablets----1件: 299
311Clavulanate1件: Clavulanic acid1件: D07711 --1件: 299
312CLAVULANIC ACID1件: Clavulanic acid1件: D07711 --1件: 299
313Clindamycin1件: Clindamycin1件: D00277 --2件: 46, 299
314CLORURO SODICO 7%----1件: 299
315Cobamamide1件: Cobamamide1件: D00042 --1件: 299
316Colfinair 2 MIU Powder for Nebuliser Solution----1件: 299
317Colimicina----1件: 299
318COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299
319Colimycine----1件: 299
320COLIMYCINE inhalation----1件: 299
321COLIMYCINE injectable----1件: 299
322COLISTIMETATO SODICO----1件: 299
323Colistimethat-Natrium----1件: 299
324COLISTIMETHATE1件: Colistimethate---1件: 299
325Colistimethate 75 mg inhaled two times daily1件: Colistimethate---1件: 299
326COLISTIMETHATE SODIUM1件: Colistimethate---1件: 299
327COLISTIMETHATE SODIUM (A COMPONENT)1件: Colistimethate---1件: 299
328Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		1件: D07746 --1件: 299
329Colistimethate sodium (CMS)1件: Colistimethate---1件: 299
330Colistimethate sodium (promixin)1件: Colistimethate---1件: 299
331COLISTIN1件: Colistin1件: D07746 --1件: 299
332Colistin CF1件: Colistin1件: D07746 --1件: 299
333Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin1件: D07746 --1件: 299
334COLISTIN MESILATE SODIUM1件: Colistin1件: D07746 --1件: 299
335Colistineb----1件: 299
336COLISTINEB 2MUI----1件: 299
337Colobreathe1件: Colistimethate---1件: 299
338Colomycin----1件: 299
339Comirnaty1件: Tozinameran1件: D11971 --5件: 13, 46, 51, 53, 299
340Comirnaty concentrate for dispersion for injection1件: Tozinameran1件: D11971 --2件: 53, 299
341Compound 1a----2件: 246, 299
342Continuous infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
343Continuous infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
344Continuous infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
345Continuous infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
346Continuous infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
347Control----4件: 6, 46, 168, 299
348Control Group 0.9% Isotonic Saline----1件: 299
349Control multivitamin----1件: 299
350COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299
351COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299
352COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299
353COVID-19 Vaccine (ChAdOx1-S [recombinant])----3件: 46, 51, 299
354COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
355Covid-19 Vaccine Janssen1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
356COVID-19 Vaccine Janssen suspension for injection1件: Janssen COVID-19 Vaccine1件: D12129 --1件: 299
357COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
358COVID-19 Vaccine Moderna1件: Moderna COVID-19 Vaccine1件: D12114 --4件: 46, 51, 65, 299
359COVID-19 Vaccine Moderna dispersion for injection1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
360CPX----1件: 299
361CR0021件: CR002---1件: 299
362CR002 Liquid API1件: CR002---1件: 299
363CRC3357, ZK-355322, Leukoton----1件: 299
364CREON----2件: 298, 299
365Creon 10.000, hårde enterokapsler----1件: 299
366Creon 10000----2件: 298, 299
367CREON 10000 Capsules----1件: 299
368Creon 25.000, hårde enterokapsler----1件: 299
369Creon 25000----2件: 298, 299
370Creon 40.000, hårde enterokapsler----1件: 299
371CREON IR----1件: 299
372Creon N----1件: 299
373CREON N 25000----1件: 299
374Creon®----1件: 299
375Creon® (DR/GR)----1件: 299
376Creon® 25,000----1件: 299
377Crestor1件: Rosuvastatin1件: D08492 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 49, 79, 299
378CSL787----1件: 299
379CTX-4430----1件: 299
380Curcuma Longa1件: Turmeric---2件: 96, 299
381Curcuma Longa Extract1件: Turmeric---1件: 299
382Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg1件: Turmeric---1件: 299
383Curcumin1件: Curcumin---10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299
384CYC202----1件: 299
385CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL]----1件: 299
386CYSTAGON1件: Cysteamine1件: D03634 --3件: 8, 19, 299
387Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine1件: D03634 --1件: 299
388Cysteamine1件: Cysteamine1件: D03634 --4件: 8, 19, 21, 299
389Cysteamine Bitartrate1件: Cysteamine1件: D03634 --4件: 8, 19, 21, 299
390Cysteamine bitartrate (Cystagon)1件: Cysteamine1件: D03634 --1件: 299
391Cystic Fibrosis Ready to Use Supplemental Food----1件: 299
392Cystic fibrosis transmembrane conductance regulator----1件: 299
393D-a-tocopheryl PEG 1000 succinate----1件: 299
394D-glucitol1件: Sorbitol1件: D00096 --2件: 28, 299
395D-IVA----1件: 299
396D6-25-hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
397DCI----2件: 6, 299
398DCI 1020----1件: 299
399Decolonization----1件: 299
400Denosumab1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬8件: 46, 50, 70, 93, 95, 96, 274, 299
401Denufosol1件: Denufosol---1件: 299
402Denufosol tetrasodium (INS37217)1件: Denufosol---1件: 299
403Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299
404Denufosol tetrasodium Inhalation Solution1件: Denufosol---1件: 299
405DEPELESTAT----1件: 299
406Desoxyribonuclease1件: Desoxyribonuclease---1件: 299
407Detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
408Detoxifying agents for antineoplastic treatment----2件: 299, 337
409Deuterated Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
410DEUTIVACAFTOR1件: Deutivacaftor1件: D11423 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
411Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
412Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
413DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301
414DICLOXACILLIN1件: Dicloxacillin1件: D02348 --1件: 299
415Diet----4件: 86, 97, 240, 299
416Digitoxin1件: Digitoxin1件: D00297 4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬		18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
417Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
418Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301
419Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299
420Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299
421Docosahexanoic Acid1件: Doconexent---1件: 299
422Docosahexanoic Acid Supplement1件: Doconexent---1件: 299
423Dopamina1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
424DORIBAX1件: Doripenem1件: D03895 --1件: 299
425Doripenem1件: Doripenem1件: D03895 --1件: 299
426DORIPENEM HYDRATE1件: Doripenem1件: D03895 --1件: 299
427Dornase alfa1件: Dornase alfa1件: D03896 --2件: 53, 299
428Dornase alfa (Pulmozyme)1件: Dornase alfa1件: D03896 --1件: 299
429Dornase alfa [Pulmozyme®]1件: Dornase alfa1件: D03896 --1件: 299
430Dornase alpha1件: Dornase alfa1件: D03896 --1件: 299
431Doxycyclin1件: Doxycycline2件: D00307 ,
D07876 		--2件: 97, 299
432Doxycycline1件: Doxycycline2件: D00307 ,
D07876 		--17件: 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299
433DP Mannitol1件: Mannitol1件: D00062 --1件: 299
434Dry powder tobramycin1件: Tobramycin1件: D00063 --1件: 299
435DTPA1件: Pentetic acid1件: D05422 --2件: 28, 299
436Dulaglutide1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
437Dulaglutide 0.75Mg/0.5Ml Inj Pen1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
438DURAMYCIN1件: Lancovutide---1件: 299
439Duramycin, 2622U901件: Lancovutide---1件: 299
440DX-890----1件: 299
441Ebselen1件: Ebselen---1件: 299
442ECGC----1件: 299
443EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299
444EGCG + Tocotrienol2件: Epigallocatechin gallate,
Tocotrienol		---1件: 299
445Elasomeran1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
446ELEXACAFTOR1件: Elexacaftor1件: D11507 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
447Elexacaftor / Ivacaftor / Tezacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
448Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
449Elexacaftor-tezacaftor-ivacaftor exposure3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
450Elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
451ELX----1件: 299
452ELX (VX-445)/TEZ (VX-661)/IVA (VX-770)----1件: 299
453ELX-021件: ELX-02---3件: 19, 218, 299
454ELX/TEZ/IVA----1件: 299
455EMEA/H/C/000125----1件: 299
456End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----2件: 113, 299
457Engineerd Protein Inhibitor of human Neutrophil Elastase----1件: 299
458Engineered Protein Inhibitor of human Neutrophil Elastase----1件: 299
459Ensure High Protein----1件: 299
460Ensure plus----1件: 299
461EPI-hNE4 DX-890----1件: 299
462Ergocalciferol1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 46, 84, 96, 97, 299
463Ergocalciferol (vitamin D2)1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
464Esomeprazole1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
465Essential amino acid intake + Leucine vs total AA supplement1件: Leucine1件: D00030 --1件: 299
466Estradiol1件: Estradiol1件: D00105 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬7件: 13, 46, 49, 65, 76, 226, 299
467Estradiol 2 mg1件: Estradiol1件: D00105 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
468ETD001 multiple once daily doses----1件: 299
469ETD001 multiple twice daily doses----1件: 299
470ETD001 single dose----1件: 299
471Ethambutol1件: Ethambutol1件: D07925 --2件: 84, 299
472Ethinyl estradiol2件: Estradiol,
Ethinylestradiol		2件: D00105 ,
D00554 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 46, 49, 299
473EU Orphan Designation Number EU/3/02/120----1件: 299
474EUR-1008----1件: 299
475EUR-1008 (APT-1008)----1件: 299
476EUR-1008 25,000 Units----1件: 299
477Ex-vivo approach concerning 25 patients----2件: 102, 299
478Exercise----1件: 299
479EZ-2053----2件: 85, 299
480EZ-2053 5mg/kg----2件: 85, 299
481F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299
482Fasenra1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
483FDL1691件: FDL169---1件: 299
484FDL176----1件: 299
485FDL176 & FDL169 coadministration1件: FDL169---1件: 299
486Fenretinide1件: Fenretinide1件: D04162 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299
487Ferinject----2件: 86, 299
488FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: D08920 --4件: 86, 96, 97, 299
489Ferrous sulfate 325mg1件: Sulfate ion---1件: 299
490Finely ground flaxseed powder1件: Flax seed---1件: 299
491Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299
492Flaxseed1件: Flax seed---2件: 97, 299
493FLUCLOXACILLIN1件: Flucloxacillin1件: D04196 --1件: 299
494Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: D04196 --1件: 299
495FLUCLOXACILLIN SODIUM1件: Flucloxacillin1件: D04196 --1件: 299
496Flucloxicillin----1件: 299
497FluMist1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
498Flumist®1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
499Fluticasone1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299
500FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299
501Formoterol1件: Formoterol1件: D07990 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299
502Fortum----1件: 299
503FTI, AZLI----1件: 299
504Fucidin1件: Fusidic acid1件: D04281 --1件: 299
505Fucidin Tablets1件: Fusidic acid1件: D04281 --1件: 299
506Fusidate1件: Fusidic acid1件: D04281 --1件: 299
507FUSIDIC ACID1件: Fusidic acid1件: D04281 --1件: 299
508Fusidin----1件: 299
509G1117337----2件: 67, 299
510G914167----1件: 299
511G957389----1件: 299
512GALICAFTOR1件: Galicaftor1件: D11724 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
513Gallium nitrate2件: Gallium nitrate,
Nitrate		2件: D00940 ,
D02313 		--1件: 299
514Garlic1件: Garlic1件: D12020 --1件: 299
515Genetic testing----3件: 6, 90, 299
516GENISTEIN1件: Genistein1件: D11680 --2件: 19, 299
517Genistein (Unconjugated Isoflavones 100)1件: Genistein1件: D11680 --1件: 299
518Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----1件: 299
519Gentamicin1件: Gentamicin1件: D08013 --3件: 36, 113, 299
520Gernebcin----1件: 299
521Gernebcin 80 mg----1件: 299
522Ghrelin1件: Lenomorelin---6件: 6, 78, 193, 201, 202, 299
523GIP----1件: 299
524Giving DHA-rich supplement----1件: 299
525Glargine----1件: 299
526Glargine insulin----1件: 299
527GLP-1----1件: 299
528GLPG1837----1件: 299
529GLPG1837 dose 1----1件: 299
530GLPG1837 dose 2----1件: 299
531GLPG1837 dose 3----1件: 299
532GLPG2222----1件: 299
533GLPG2222 100 mg----1件: 299
534GLPG2222 150 mg q.d.----1件: 299
535GLPG2222 200 mg----1件: 299
536GLPG2222 300 mg q.d.----1件: 299
537GLPG2222 400 mg----1件: 299
538GLPG2222 50 mg----1件: 299
539GLPG2451 dose regimen A----1件: 299
540GLPG2451 dose regimen B----1件: 299
541GLPG2737----2件: 67, 299
542GLPG2737 single dose----1件: 299
543GLPG3067----1件: 299
544GLPG3067 single dose----1件: 299
545Glucose1件: Dextrose, unspecified form---12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299
546Glutamine1件: L-Glutamine1件: D00015 --8件: 87, 89, 96, 97, 113, 222, 245, 299
547Glutathione1件: Glutathione2件: D00014 ,
D00031 		--2件: 6, 299
548GLUTATHIONE SODIUM1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
549GLYCINE1件: Glycine1件: D00011 --5件: 35, 60, 86, 226, 299
550Glycine Buffer1件: Glycine1件: D00011 --1件: 299
551GlycosBio Nutritional Supplement----1件: 299
552GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----1件: 299
553Growth hormone1件: Somatotropin---14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299
554GS-5737----1件: 299
555GS-57451件: GS-5745---4件: 46, 96, 97, 299
556GS-9411----1件: 299
557GSH----2件: 6, 299
558GSH (Glutathione)1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
559H02 - Corticosteroidi Sistemici----1件: 299
560H5.001CBCFTR----1件: 299
561Helium1件: Helium1件: D04420 --3件: 228, 299, 330
562Helium-32件: Helium,
Helium He-3		1件: D04420 --2件: 228, 299
563Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬11件: 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317
564Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299
565Heparin Sodium1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬2件: 280, 299
566Heracillin----1件: 299
567High dose of budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
568High-Dose Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
569HMSCs----1件: 299
570HP 129Xe----1件: 299
571HP 3He----1件: 299
572HSK31858----1件: 299
573Human recombinant growth hormone1件: Somatotropin---2件: 13, 299
574Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
575Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
576Hyperglycemic clamp----1件: 299
577Hyperglycemic Clamp with concurrent GIP infusion----1件: 299
578Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299
579Hyperpolarized Helium-32件: Helium,
Helium He-3		1件: D04420 --1件: 299
580Hyperpolarized Helium-3 MRI of the chest2件: Helium,
Helium He-3		1件: D04420 --1件: 299
581Hyperpolarized Xe129----4件: 51, 85, 86, 299
582Hyperpolarized Xenon1件: Xenon2件: D01901 ,
D06339 		--1件: 299
583Hyperpolarized Xenon 1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
584Hyperpolarized Xenon gas1件: Xenon2件: D01901 ,
D06339 		--1件: 299
585Hyperpolarized xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
586Hypertonic bicarbonate----1件: 299
587HYPERTONIC SALINE----1件: 299
588Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299
589Hypertonic saline (7%)----1件: 299
590Hypertonic saline 6% -----1件: 299
591Hypertonic Saline 7%1件: Sodium chloride1件: D02056 --1件: 299
592Hypertonic saline solution1件: Sodium chloride1件: D02056 --1件: 299
593Ibuprofen1件: Ibuprofen1件: D00126 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
594Icenticaftor----1件: 299
595ICS+LABA----1件: 299
596IDPM----1件: 299
597IDPM: Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
598IGE025----1件: 299
599IgY----1件: 299
600IMIPENEM1件: Imipenem2件: D00206 ,
D04515 		--2件: 60, 299
601Imipenem/Cilastatin/Relebactam3件: Cilastatin,
Imipenem,
Relebactam		4件: D00206 ,
D04515 ,
D07698 ,
D10726 		1件: DPEP1 💬-1件: 299
602Impact----5件: 46, 50, 53, 85, 299
603Impact-Nutridrink----1件: 299
604In-vitro approach concerning 25 patients----2件: 102, 299
605Increlex1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬4件: 65, 78, 96, 299
606INCRELEX*SC 1FL 4ML 10MG/ML1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 299
607Indium1件: Indium---3件: 28, 84, 299
608Indium-DTPA2件: Indium,
Pentetic acid		1件: D05422 --1件: 299
609INDUSIL*OS GTT FL 30MG+FL 15ML----1件: 299
610Influenza vaccination----1件: 299
611Inhaled 7% hypertonic saline (HS)----1件: 299
612Inhaled AR-501----1件: 299
613Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
614Inhaled hypertonic saline (7%)----1件: 299
615Inhaled Mannitol1件: Mannitol1件: D00062 --1件: 299
616Inhaled Reduced Glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
617Inhaled SNSP113----1件: 299
618Inhaled Sodium Pyruvate----1件: 299
619Inhaled tobramycin1件: Tobramycin1件: D00063 --1件: 299
620Inhaled Vancomycin1件: Vancomycin1件: D00212 --1件: 299
621Initiation of CFTR Modulator----1件: 299
622INOmax1件: Nitric Oxide1件: D00074 --3件: 85, 294, 299
623INOmax 400ppm mol/mol inhalation gas1件: Nitric Oxide1件: D00074 --2件: 85, 299
624INS1007----2件: 44, 299
625INS1007 10 mg oral tablet----1件: 299
626INS1007 25 mg oral tablet----1件: 299
627Insulin----6件: 6, 13, 46, 75, 78, 299
628Insulin Asparte----1件: 299
629Insulin detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
630Insulin detemir [rDNA origin] injection1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
631Insulin glargine1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
632Insuline humaine recombinante----1件: 299
633Interferon Gamma1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326
634INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326
635Intermittent, short infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
636Intermittent, short infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
637Intermittent, short infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
638Intermittent, short infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
639Intermittent, short infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
640Inulin1件: Inulin1件: D00171 --4件: 6, 96, 156, 299
641IONIS-ENaCRx----1件: 299
642ISOTONIC SALINE----1件: 299
643Isotonic saline 0.9%1件: Sodium chloride1件: D02056 --1件: 299
644Itraconazole1件: Itraconazole1件: D00350 --6件: 3, 46, 65, 96, 227, 299
645Itraconazole/voriconazole2件: Itraconazole,
Voriconazole		2件: D00350 ,
D00578 		--1件: 299
646IV amikacin1件: Amikacin1件: D02543 --1件: 299
647IV ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
648IV meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
649IV piperacillin-tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
650IV ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
651IV tobramycin1件: Tobramycin1件: D00063 --1件: 299
652IV vancomycin hydrochloride1件: Vancomycin1件: D00212 --1件: 299
653IVA----1件: 299
654IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
655Ivacaftor (proposed INN)1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
656Ivacaftor 125mg tablet1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
657Ivacaftor 150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
658Ivacaftor 150 mg or 250 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
659Ivacaftor 25 mg/75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
660IVACAFTOR 59,5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
661IVACAFTOR 59.5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
662Ivacaftor 75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
663Ivacaftor 75 mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
664IVACAFTOR 75mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
665Ivacaftor Exposed1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
666Ivacaftor or elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
667Ivacaftor+lumacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
668Ivacaftor/Ataluren2件: Ataluren,
Ivacaftor		2件: D09323 ,
D09916 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
669Ivacaftor/Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
670Ivacaftor/Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
671J01GB01----1件: 299
672JBT-101----4件: 49, 50, 51, 299
673JBT-101 (lenabasum)----1件: 299
674JBT101----1件: 299
675Kaftrio1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
676Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
677Kalydeco 150 mg film-c1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
678Kalydeco 150 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
679Kalydeco 150mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
680KB0011件: KB001---1件: 299
681KB001-A1件: KB001---1件: 299
682KB407 (Nebulization)----1件: 299
683Ketone Monoester----1件: 299
684Kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬9件: 28, 41, 46, 49, 65, 106, 107, 266, 299
685Klacid----1件: 299
686Kreon 25 000----1件: 299
687Kreon 25,000 Units----1件: 299
688Kreon 25000----2件: 298, 299
689KREON de Liberación Inmediata----1件: 299
690KREON N 25000----1件: 299
691Kreon® 25,000----1件: 299
692L-alanine1件: Alanine1件: D00012 --1件: 299
693L-arginine2件: Arginine,
L-arginine		1件: D02982 --8件: 46, 67, 78, 96, 97, 98, 113, 299
694L-Glutamine1件: L-Glutamine1件: D00015 --2件: 113, 299
695L-Lysine N acetylcysteinate1件: Lysine1件: D02304 --1件: 299
696L-Lysine N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
697L-Lysine- N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
698L-Lysine-N-acetyl-L-cysteinate1件: Lysine1件: D02304 --1件: 299
699L-Lysine-N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
700LABA/LAMA----1件: 299
701Lactic acid1件: Lactic acid1件: D00111 --1件: 299
702Lactic acid producing organisms1件: Lactic acid1件: D00111 --1件: 299
703Lactizole nebulization----1件: 299
704Lactobacillus1件: Lactobacillus delbrueckii bulgaricus---5件: 6, 46, 51, 97, 299
705LACTOBACILLUS REUTERI1件: Lactobacillus reuteri---2件: 97, 299
706Lactobacillus rhamnosus1件: Lactobacillus delbrueckii bulgaricus---1件: 299
707Lactobacillus rhamnosus GG1件: Lactobacillus delbrueckii bulgaricus---1件: 299
708Lansoprazole1件: Lansoprazole1件: D00355 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬7件: 63, 71, 85, 98, 166, 222, 299
709Lantus 100 units/ml solution for injection in a cartridge----1件: 299
710LANTUS*SC 5CAR3ML100UI/ML1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
711Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299
712LAU-7b----1件: 299
713Lefamulin1件: Lefamulin1件: D11631 --1件: 299
714Lenabasum----3件: 50, 51, 299
715Lenabasum 20 mg----2件: 51, 299
716Lenabasum 5 mg----2件: 51, 299
717Leucine1件: Leucine1件: D00030 --6件: 6, 19, 65, 283, 284, 299
718Levemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
719Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
720Levemir FlexPen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
721Levemir Penfill1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
722Levofloxacin1件: Levofloxacin2件: D00588 ,
D08120 		--4件: 46, 53, 84, 299
723LEVOFLOXACIN HEMIHYDRATE1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
724Levofloxacin Kabi1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
725Linez----1件: 299
726LINEZOLID1件: Linezolid1件: D00947 --1件: 299
727Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299
728Linoleic acid supplementation1件: Linoleic acid---1件: 299
729LIPASA----1件: 299
730LIPASE----2件: 298, 299
731Lipase CLEC----1件: 299
732LIPASE LIP2----1件: 299
733Lipase Lip2 from Yarrowia lipolytica----1件: 299
734Lipitor1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 51, 96, 299
735Liposomal Amikacin1件: Amikacin1件: D02543 --1件: 299
736Liposomal Amikacin (Arikace TM)1件: Amikacin1件: D02543 --1件: 299
737Liposomal Amikacin (Arikace™)1件: Amikacin1件: D02543 --1件: 299
738Liposomal amikacin for inhalation1件: Amikacin1件: D02543 --1件: 299
739Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin1件: D02543 --1件: 299
740Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: D00203 --1件: 299
741Liprotamasa----1件: 299
742Liprotamase----2件: 298, 299
743Liprotamase Powder for Oral Solution----1件: 299
744Loestrin (norethindrone acetate and ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		3件: D00105 ,
D00182 ,
D00554 		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
745Lonodelestat----1件: 299
746Losartan1件: Losartan1件: D08146 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
747LU 70274----1件: 299
748LUBIPROSTONE1件: Lubiprostone1件: D04790 1件: CLCN2 💬1件: Mineral absorption 💬4件: 6, 13, 290, 299
749Lucinactant1件: Lucinactant1件: D04792 --1件: 299
750Lucinactant first1件: Lucinactant1件: D04792 --1件: 299
751LUM----1件: 299
752LUM/IVA----1件: 299
753LUM/IVA fixed-dose combination----1件: 299
754LUMACAFTOR1件: Lumacaftor1件: D10134 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
755Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
756Lumacaftor plus Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
757Lumacaftor Plus Ivacaftor Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
758Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
759Lumacaftor-ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
760Lumacaftor-Ivacaftor treatment2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
761Lumacaftor/Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
762Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
763Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
764Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
765Lumacaftor/ivacaftor 200mg/83mg tablet2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
766Lym-X-Sorb powder----1件: 299
767Lysine1件: Lysine1件: D02304 --4件: 13, 97, 228, 299
768Lysomucil 10 %----1件: 299
769Macrogol1件: Polyethylene glycol1件: D03370 --1件: 299
770Macrogol 40001件: Polyethylene glycol1件: D03370 --1件: 299
771MAG-DHA----1件: 299
772Mannite1件: Mannitol1件: D00062 --1件: 299
773Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
774Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: D00062 ,
D03896 		--1件: 299
775Mannitol Inhalant Product1件: Mannitol1件: D00062 --1件: 299
776Mannitol inhalation powder1件: Mannitol1件: D00062 --1件: 299
777Matched isoglycemic clamp----1件: 299
778Mecasermin1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299
779MEDI-563----5件: 44, 45, 98, 162, 299
780Medical Grade Oxygen1件: Oxygen1件: D00003 --1件: 299
781Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
782Menadiol Diphosphate1件: Menadiol diphosphate1件: D08176 --1件: 299
783Menadiol sodium diphosphate1件: Kappadione1件: D04908 --1件: 299
784MEROPENEM1件: Meropenem2件: D02222 ,
D08185 		--2件: 60, 299
785Meropenem Fresenius Kabi1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
786Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
787Meropenem Infusion1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
788MEROPENEM TRIHYDRATE1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
789Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299
790Metformin1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
791METFORMIN HYDROCHLORIDE1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301
792Metformine1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬3件: 46, 81, 299
793Metformine HCL 500 PCH1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 299
794Midazolam1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
795MIGLUSTAT1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
796Minocycline1件: Minocycline1件: D05045 --13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299
797Minocycline Hydrochloride1件: Minocycline1件: D05045 --4件: 13, 201, 206, 299
798MMF----16件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299
799Modified lipid formulation----1件: 299
800Modified Oral Glucose Tolerance Test (50g 4-hours)1件: Dextrose, unspecified form---1件: 299
801Molgramostim1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬3件: 97, 229, 299
802Molgramostim nebulizer solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 299
803MOLI 1901----1件: 299
804Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
805Moli1901----1件: 299
806Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
807Moxifloxacin1件: Moxifloxacin1件: D08237 --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
808Moxifloxacin Hydrochloride1件: Moxifloxacin1件: D08237 --2件: 113, 299
809MP-376----1件: 299
810MP-376 (Levofloxacin Solution for Inhalation)1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
811MRI with PFP----1件: 299
812MRT5005----1件: 299
813MS1819----2件: 298, 299
814MS1819-SD1件: MS-1819---2件: 298, 299
815MSI-1995----1件: 299
816MTT----1件: 299
817Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299
818Mucolysin----1件: 299
819Mucomyst1件: Acetylcysteine1件: D00221 --1件: 299
820Multienzymes (lipase, protease etc.)----2件: 298, 299
821Mupirocin1件: Mupirocin1件: D01076 --2件: 227, 299
822Mupirocin Intranasal Creme1件: Mupirocin1件: D01076 --1件: 299
823N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299
824N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299
825N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299
826N-acetylcystein----1件: 299
827N-Acetylcysteine1件: Acetylcysteine1件: D00221 --13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337
828N-acetylcysteine (NAC)1件: Acetylcysteine1件: D00221 --2件: 51, 299
829N6022----1件: 299
830N91115----1件: 299
831NAC----4件: 51, 85, 90, 299
832Nacystelyn----1件: 299
833Nacystelyn®----1件: 299
834NAL----2件: 6, 299
835Nasal Aztreonam1件: Aztreonam1件: D00240 --1件: 299
836Navocaftor----1件: 299
837NEB/01-07----1件: 299
838Nebcin----1件: 299
839Nebcin (tobramycin)1件: Tobramycin1件: D00063 --1件: 299
840Nebcinal----1件: 299
841Nebcinal Tobi----1件: 299
842NEBCINE----1件: 299
843Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
844Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
845Nebulization tobramycin1件: Tobramycin1件: D00063 --1件: 299
846Nexium1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
847Nexium 201件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
848Nitrate1件: Nitrate1件: D02313 --4件: 58, 67, 113, 299
849NITRIC OXIDE1件: Nitric Oxide1件: D00074 --7件: 85, 86, 88, 210, 251, 294, 299
850Nitric Oxide 160 ppm1件: Nitric Oxide1件: D00074 --1件: 299
851Nitric Oxide for inhalation1件: Nitric Oxide1件: D00074 --2件: 86, 299
852Nitrogen1件: Nitrogen1件: D00083 --5件: 5, 6, 17, 211, 299
853NO----9件: 6, 46, 58, 62, 86, 97, 222, 299, 321
854None----20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337
855None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299
856Norethindrone1件: Norethisterone1件: D00182 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299
857Norgestimate1件: Norgestimate1件: D05209 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 299
858Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299
859Normal saline IV, salt tablets----1件: 299
860Normal saline solution1件: Sodium chloride1件: D02056 --1件: 299
861Normal saline:----1件: 299
862Norvir1件: Ritonavir1件: D00427 --2件: 265, 299
863Norvir 100 mg film-coated tablets----1件: 299
864Novamin----1件: 299
865Novo Rapid----1件: 299
866Novo Rapid Insulin (Novonordisk)----1件: 299
867NovoNorm 0.5 mg----1件: 299
868NovoNorm 1 mg----1件: 299
869NovoNorm 2 mg----1件: 299
870Novorapid / humalog short acting insulin----1件: 299
871NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299
872NovoRapid Aspartate----1件: 299
873Noxafil1件: Posaconazole1件: D02555 --3件: 60, 65, 299
874NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: D02555 --1件: 299
875NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: D02555 --1件: 299
876NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: D02555 --1件: 299
877Noxafil 100 mg1件: Posaconazole1件: D02555 --1件: 299
878Noxafil 100 mg Tablets Gastro-Resistant1件: Posaconazole1件: D02555 --1件: 299
879Noxafil®1件: Posaconazole1件: D02555 --2件: 60, 299
880Nutridrink-Impact----1件: 299
881Nutropin AQ----4件: 78, 134, 193, 299
882Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin---1件: 299
883OGT 918----2件: 19, 299
884Oleic Acid1件: Oleic Acid1件: D02315 --2件: 13, 299
885Oleic acid supplementation1件: Oleic Acid1件: D02315 --1件: 299
886OligoG----1件: 299
887OligoG (60 mg/ml)----1件: 299
888OLIGOG CF-5/20----1件: 299
889OligoG CF-5/20 - 17.5 mg----1件: 299
890OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
891OligoG CF/20 - 27.5 mg----1件: 299
892OligoG CF/20 - 37.5 mg----1件: 299
893OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
894OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
895OligoG DPI----1件: 299
896OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment1件: Alginic acid1件: D02324 --1件: 299
897Oligomer of Sodium Alginate1件: Alginic acid1件: D02324 --1件: 299
898Omadacycline1件: Omadacycline1件: D09647 --1件: 299
899Omadacycline Injection [Nuzyra]1件: Omadacycline1件: D09647 --1件: 299
900Omadacycline Oral Tablet [Nuzyra]1件: Omadacycline1件: D09647 --1件: 299
901OMALIZUMAB1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299
902Omega 3----3件: 13, 53, 299
903Omega 3 Premium----1件: 299
904Omega-31件: Omega-3 fatty acids---7件: 13, 46, 49, 66, 79, 96, 299
905Omega-3 triglycerides1件: Omega-3 fatty acids---1件: 299
906OMEGA-3-ACID TRIGLYCERIDES1件: Omega-3 fatty acids---1件: 299
907Omeprazole1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299
908Omeprazole 40mg Capsule1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
909Once-daily insulin detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
910Oral Aztreonam1件: Aztreonam1件: D00240 --1件: 299
911Oral ciprofloxacin1件: Ciprofloxacin1件: D00186 --1件: 299
912Oral ciprofloxacin plus inhaled colistin2件: Ciprofloxacin,
Colistin		2件: D00186 ,
D07746 		--1件: 299
913Oral Glucose Tolerance test (75g 2-hour)1件: Dextrose, unspecified form---1件: 299
914Oral Glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
915Oral reduced l-glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
916Oral roflumilast1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299
917Orkambi1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
918Orkambi 100 mg/125 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
919Orkambi 200 mg/125 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
920Orkambi: contains lumacaftor and ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
921Orkambi®1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
922Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg3件: Estradiol,
Ethinylestradiol,
Norgestimate		3件: D00105 ,
D00554 ,
D05209 		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
923OSCN-----1件: 299
924Oseltamivir1件: Oseltamivir1件: D08306 --2件: 97, 299
925Osmohale----1件: 299
926Other non-sponsor pancreatic enzyme replacement therapy----1件: 299
927Other respiratory system products----1件: 299
928Oxygen1件: Oxygen1件: D00003 --13件: 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330
929P-1037----1件: 299
930PAAG15----1件: 299
931Pancreas Powder----1件: 299
932Pancrease----1件: 299
933PANCREASE MT----1件: 299
934Pancrease MT 10.5, or MT 21----1件: 299
935PANCREASLIPASE----1件: 299
936Pancreatin1件: Pancrelipase1件: D05349 --2件: 298, 299
937PANCREATIN (PAncreas Powder)1件: Pancrelipase1件: D05349 --1件: 299
938PANCREATINA----1件: 299
939PANCREATINA (Páncreas Polvo----1件: 299
940PANCREATINA (Páncreas Polvo)----1件: 299
941PANCREAZE----1件: 299
942PANCREAZE®----1件: 299
943PANCRECARB® (pancrelipase)1件: Pancrelipase1件: D05349 --1件: 299
944Pancrelipase1件: Pancrelipase1件: D05349 --2件: 298, 299
945PANCRELIPASE AMYLASE1件: Pancrelipase1件: D05349 --1件: 299
946Pancrelipase Delayed Release1件: Pancrelipase1件: D05349 --1件: 299
947Pancrelipase Delayed Release Capsule1件: Pancrelipase1件: D05349 --2件: 298, 299
948Pancrelipase Microtablets1件: Pancrelipase1件: D05349 --1件: 299
949Pancrelipase with bicarbonate1件: Pancrelipase1件: D05349 --1件: 299
950Pancrelipase/Pancreas Powder1件: Pancrelipase1件: D05349 --2件: 298, 299
951Pankreatin----1件: 299
952PANZYTRAT 25000----1件: 299
953Panzytrat® 25,000----1件: 299
954Panzytrat® ok----1件: 299
955PBI4050----2件: 85, 299
956PC945----1件: 299
957PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337
958Perfluorinated gas/oxygen mixture1件: Oxygen1件: D00003 --1件: 299
959PERTZYE----1件: 299
960PFP----1件: 299
961PGM169/GL67A----1件: 299
962PGT-1 gene lipid complex----1件: 299
963PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
964Phosphate1件: Phosphate ion---32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
965Physiologic serum nebulized nasally----1件: 299
966Physiological solution----1件: 299
967Pilocarpine1件: Pilocarpine1件: D00525 2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
968Pilocarpine Nitrate 5%2件: Nitrate,
Pilocarpine		2件: D00525 ,
D02313 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
969Pioglitazone1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
970PIPERACILLIN1件: Piperacillin2件: D02251 ,
D08380 		--1件: 299
971PIPERACILLIN SODIUM1件: Piperacillin2件: D02251 ,
D08380 		--1件: 299
972Piperacillin sodium , tazobactam sodium2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
973Piperacillin with Tazobactam (tazocin)2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
974Piperacillin-tazobactam combination product2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
975Piperacillin/Tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
976Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
977Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
978Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
979PL 0010/0211----1件: 299
980PLERIXAFOR1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬4件: 20, 65, 285, 299
981Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299
982PO azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
983PO ciprofloxacin1件: Ciprofloxacin1件: D00186 --1件: 299
984POL6014----1件: 299
985POL7080----1件: 299
986Polyethylene glycol1件: Polyethylene glycol1件: D03370 --7件: 6, 78, 96, 97, 235, 276, 299
987Polyethylene Glycol 33501件: Polyethylene glycol1件: D03370 --2件: 96, 299
988Porcine (pig) PERT----1件: 299
989Porcine PERT----1件: 299
990Posaconazole1件: Posaconazole1件: D02555 --3件: 60, 65, 299
991Posaconazole 100 MG [Noxafil]1件: Posaconazole1件: D02555 --1件: 299
992Posaconazole 40 MG/ML1件: Posaconazole1件: D02555 --1件: 299
993POSACONAZOLO----1件: 299
994PPI treatment----1件: 299
995PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
996Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
997PREFOLIC*30CPR GASTROR 15MG----1件: 299
998Probiotic----8件: 2, 6, 93, 96, 97, 193, 266, 299
999Progesterone1件: Progesterone1件: D00066 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬2件: 76, 299
1000Prograft capsules----1件: 299
1001Prolastin----3件: 231, 298, 299
1002Prolastin (drug)----1件: 299
1003Promixin----1件: 299
1004Promixin 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1005PROMIXIN*NEBUL 30MONOD 1MUI----1件: 299
1006Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1007Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----1件: 299
1008Promixin/Tadim----1件: 299
1009PROTEASA----1件: 299
1010PROTEASE----1件: 299
1011PsAer IgY----1件: 299
1012PTC-0161480----2件: 246, 299
1013PTC-124----2件: 246, 299
1014PTC-C124----2件: 246, 299
1015PTC124----4件: 19, 113, 246, 299
1016PTI-4281件: PTI-428---1件: 299
1017PTI-8011件: PTI-801---1件: 299
1018PTI-808----1件: 299
1019Pulmaquin®----1件: 299
1020Pulmozyme1件: Dornase alfa1件: D03896 --1件: 299
1021Pulmozyme (dornase alfa)1件: Dornase alfa1件: D03896 --1件: 299
1022Pulmozyme (Dornase alpha)1件: Dornase alfa1件: D03896 --1件: 299
1023Pulmozyme single use ampule1件: Dornase alfa1件: D03896 --1件: 299
1024Pulmozyme®1件: Dornase alfa1件: D03896 --1件: 299
1025PUR118----1件: 299
1026QAU145----1件: 299
1027QBW251----1件: 299
1028QBW276----1件: 299
1029QBW276 1500mcg----1件: 299
1030QBW276 300mcg----1件: 299
1031QBW276 Succinate----1件: 299
1032QR-010----1件: 299
1033R03AC02----1件: 299
1034R03CC02----1件: 299
1035R05C B01----1件: 299
1036Radiolabelled OligoG CF-5/20 6% Solution----1件: 299
1037Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation----1件: 299
1038Radiolabelled OligoG CF-5/20 DPI----1件: 299
1039Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI)----1件: 299
1040Rapeglinide----1件: 299
1041RAVICTI1件: Glycerol phenylbutyrate1件: D10127 --2件: 251, 299
1042Ravicti high dose1件: Glycerol phenylbutyrate1件: D10127 --1件: 299
1043Ravicti low dose1件: Glycerol phenylbutyrate1件: D10127 --1件: 299
1044Recombiant human Desoxyribonuclease ( rhDNase)1件: Desoxyribonuclease---1件: 299
1045Recombinant Human DNase (Pulmozyme)1件: Dornase alfa1件: D03896 --1件: 299
1046Recombinant human IGF-1----2件: 78, 299
1047Recombinant humanized monoclonal antibody omalizumab to IgE1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299
1048Recombinant truncated SPINT2 protease inhibitor----1件: 299
1049Red Blood Cell Zn----1件: 299
1050Reduced Glutathione1件: Glutathione2件: D00014 ,
D00031 		--2件: 6, 299
1051Reduced glutathione sodium salt1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
1052Release1件: Manganese citrate---12件: 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
1053Relebactam1件: Relebactam1件: D10726 --1件: 299
1054Repaglinide1件: Repaglinide1件: D00594 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬4件: 6, 21, 46, 299
1055Repaglinide and Insulin1件: Repaglinide1件: D00594 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 299
1056Reparixin1件: Reparixin1件: D08984 2件: CXCR1,
CXCR2 💬		7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299
1057Resunab, ajulemic acid, anabasum1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
1058RhBSSL1件: Bucelipase alfa---1件: 299
1059RhDNAse----1件: 299
1060Rifampicin1件: Rifampicin1件: D00211 --6件: 6, 17, 46, 93, 299, 338
1061Rifampin1件: Rifampicin1件: D00211 --5件: 6, 13, 84, 86, 299
1062Rifaximin1件: Rifaximin1件: D02554 --8件: 6, 65, 93, 96, 97, 99, 296, 299
1063Rifaximin 550 MG Oral Tablet [XIFAXAN]1件: Rifaximin1件: D02554 --1件: 299
1064Rimactan----1件: 299
1065RIOCIGUAT1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299
1066Riociguat (Adempas, BAY63-2521)1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 51, 86, 88, 299
1067Roflumilast1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬4件: 84, 97, 206, 299
1068Roflumilast Oral Tablet1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299
1069Roscovitine----1件: 299
1070Rosuvastatin1件: Rosuvastatin1件: D08492 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
1071ROSUVASTATIN CALCIUM2件: Calcium,
Rosuvastatin		1件: D08492 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬4件: 49, 79, 97, 299
1072Roxithromycin1件: Roxithromycin1件: D01710 --2件: 46, 299
1073RPL554----1件: 299
1074RPS 2505----2件: 246, 299
1075Répaglinide----1件: 299
1076S-1226----1件: 299
1077Salbutamol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 3, 11, 49, 85, 86, 111, 256, 299
1078Salbutamol-ratiopharm® N metered-dose aerosol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1079Salbutamol-ratiopharm® N metereddose aerosol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1080Salbutamolo----1件: 299
1081Saline----10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299
1082Saline 0.9% inhalation solution----1件: 299
1083Saline solution----4件: 2, 34, 288, 299
1084Salmeterol1件: Salmeterol1件: D05792 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1085Saxagliptin1件: Saxagliptin1件: D08996 1件: DPP4 💬1件: Protein digestion and absorption 💬1件: 299
1086SB-656933 Tablets----2件: 97, 299
1087SB-656933-AAA----1件: 299
1088SB656933----1件: 299
1089SE10599----1件: 299
1090Seliciclib1件: Seliciclib---2件: 75, 299
1091Serum Zn----1件: 299
1092SF6----1件: 299
1093Short-acting Insulin (Actrapid)----1件: 299
1094Sildenafil1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
1095Sildenafil (Acute-1 hour)1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1096Sildenafil (Subchronic-4 weeks)1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1097Sildenafil 40mg oral capsule1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1098Simvastatin1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
1099Simvastatin treatment for 28 days1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 299
1100SIN ASIGNAR----1件: 299
1101Sitagliptin1件: Sitagliptin1件: D08516 1件: DPP4 💬1件: Protein digestion and absorption 💬4件: 6, 75, 233, 299
1102SLIT Amikacin1件: Amikacin1件: D02543 --1件: 299
1103SLIT(TM) Amikacin1件: Amikacin1件: D02543 --1件: 299
1104SMX----1件: 299
1105SNSP113----1件: 299
1106Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca----1件: 299
1107Sodium 4-Phenylbutyrate1件: Phenylbutyric acid---1件: 299
1108Sodium 4-Phenylbutyrate (4PBA)1件: Phenylbutyric acid---1件: 299
1109SODIUM ALGINATE1件: Alginic acid1件: D02324 --1件: 299
1110Sodium Bicarbonate1件: Sodium bicarbonate1件: D01203 --1件: 299
1111SODIUM BICARBONATE BP1件: Sodium bicarbonate1件: D01203 --1件: 299
1112Sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --20件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299
1113Sodium chloride (7%)2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1114Sodium chloride 0,9%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1115Sodium chloride 6%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1116SODIUM CHLORIDE 7%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1117SODIUM CHLORIDE PH. EUR.2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1118SODIUM CHLORIDE SOLUTION 0.9%2件: Chloride ion,
Sodium chloride		1件: D02056 --4件: 51, 60, 288, 299
1119Sodium Fusidate1件: Fusidic acid1件: D04281 --1件: 299
1120Sodium Pyruvate in 0.9% Sodium Chloride Solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1121Soluble fiber supplementation----1件: 299
1122Somalgen----1件: 299
1123Somatropin1件: Somatotropin---19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
1124SPI-1005 Ebselen 200mg Capsule x11件: Ebselen---1件: 299
1125SPI-1005 Ebselen 200mg Capsule x21件: Ebselen---1件: 299
1126SPI-1005 Ebselen 200mg Capsule x31件: Ebselen---1件: 299
1127Spiriva1件: Tiotropium---1件: 299
1128Spiriva Respimat1件: Tiotropium---1件: 299
1129Spiriva Respimat 2.5 mcg1件: Tiotropium---1件: 299
1130Spiriva Respimat 2.5 microgram1件: Tiotropium---1件: 299
1131Spiriva Respimat 2.5 microgram, solution for inhalation1件: Tiotropium---1件: 299
1132Sporanox1件: Itraconazole1件: D00350 --2件: 227, 299
1133Sporanox 10 mg/ml Oral Solution1件: Itraconazole1件: D00350 --1件: 299
1134Sputum----1件: 299
1135SPX-101----1件: 299
1136Ss-Adrenergic cocktail----1件: 299
1137Standard Care----2件: 81, 299
1138Standard Dose YPT-01----1件: 299
1139Standard Formula----1件: 299
1140Standard formula (Enfamil)----1件: 299
1141Standard Nutritional Supplement + PERT----1件: 299
1142Standard of care IV antibiotic(s)----1件: 299
1143Standardized turmeric root extract1件: Turmeric---1件: 299
1144STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V)----1件: 299
1145Study medication, azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
1146SUB185183----1件: 299
1147Sulfamethoxazole1件: Sulfamethoxazole1件: D00447 --5件: 44, 49, 61, 85, 299
1148Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299
1149Sulfato de amikacina1件: Amikacin1件: D02543 --1件: 299
1150Sulfur Colloid1件: Gelatin2件: D00115 ,
D06892 		--1件: 299
1151Sunflower oil1件: Sunflower oil1件: D09006 --2件: 46, 299
1152Supplementation with vitamin D2/D31件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
1153Symbiotic Formula with DHA and antioxidants----1件: 299
1154Symdeko1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1155Symdeko/Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1156Symkevi1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1157Symkevi 100mg/150mg Film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1158Synrinse----1件: 299
1159T 100 PARI----1件: 299
1160T-326----1件: 299
1161T100----1件: 299
1162T100 PARI----1件: 299
1163Ta1----1件: 299
1164Tacrolimus1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
1165Tacrolimus and MMF1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1166Tacrolimus Capsules1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 299
1167Tacrolimus prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1168Tad----1件: 299
1169TAD 600----1件: 299
1170Tadim----1件: 299
1171TAFLUPROST1件: Tafluprost1件: D06274 1件: PTGFR 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 299
1172Talniflumate1件: Talniflumate1件: D02701 --1件: 299
1173TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: D11836 --3件: 2, 93, 299
1174TAZOBACTAM1件: Tazobactam1件: D00660 --1件: 299
1175TAZOBACTAM SODIUM1件: Tazobactam1件: D00660 --1件: 299
1176TBD----5件: 19, 86, 90, 276, 299
1177TBM100----1件: 299
1178TBM100C----1件: 299
1179Technetium Sulfur Colloid1件: Gelatin2件: D00115 ,
D06892 		--1件: 299
1180Tedizolid1件: Tedizolid1件: D09685 --1件: 299
1181Tedizolid IV1件: Tedizolid1件: D09685 --1件: 299
1182Tedizolid PO1件: Tedizolid1件: D09685 --1件: 299
1183Tefibazumab1件: Tefibazumab1件: D06054 --1件: 299
1184Teicoplanin1件: Teicoplanin1件: D02142 --2件: 70, 299
1185Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.1件: Teicoplanin1件: D02142 --1件: 299
1186Telavancin1件: Telavancin---1件: 299
1187Telavancin Injection1件: Telavancin---1件: 299
1188TERLIPRESSIN1件: Terlipressin1件: D06672 3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299
1189Terlipressin acetate2件: Acetate,
Terlipressin		1件: D06672 3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299
1190TEZ----1件: 299
1191TEZ/IVA----1件: 299
1192TEZACAFTOR1件: Tezacaftor1件: D11041 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1193Tezacaftor (TEZ)1件: Tezacaftor1件: D11041 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1194Tezacaftor/Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1195Tezacaftor/Ivacaftor + Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1196Tezacaftor/Ivacaftor 100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1197Tezacaftor/Ivacaftor/100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1198TgAAVCF----1件: 299
1199Tham1件: Tromethamine1件: D00396 --1件: 299
1200The gut mycobiota and microbiota profile----1件: 299
1201The lung mycobiota and microbiota profile----1件: 299
1202Theophylline1件: Theophylline2件: D00371 ,
D06103 		18件: ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 236, 299
1203Thymosin alpha 1----1件: 299
1204Ticarcillin1件: Ticarcillin1件: D08593 --1件: 299
1205Tigerase®----1件: 299
1206Tiotropium1件: Tiotropium---3件: 55, 85, 299
1207Tiotropium bromide1件: Tiotropium---1件: 299
1208Tiotropium Bromide (monohydrate)1件: Tiotropium---1件: 299
1209Tiotropium bromide 5 mcg1件: Tiotropium---1件: 299
1210Tiotropium bromide high1件: Tiotropium---1件: 299
1211Tiotropium bromide low1件: Tiotropium---1件: 299
1212Tiotropium bromide medium1件: Tiotropium---1件: 299
1213TIOTROPIUM BROMIDE MONOHYDRATE1件: Tiotropium---1件: 299
1214Tiotropium bromide-low dose-2.5mcg1件: Tiotropium---1件: 299
1215Tiotropium Respimat1件: Tiotropium---1件: 299
1216Tiotropium Respimat 1.25 microgram solution for inhalation1件: Tiotropium---1件: 299
1217Tiotropium Respimat 1.25 microgram, solution for inhalation1件: Tiotropium---1件: 299
1218Tiotropium Respimat 1.25 micrograms solution for inhalation1件: Tiotropium---1件: 299
1219Tiotropium Respimat® inhaler1件: Tiotropium---1件: 299
1220TIP----1件: 299
1221TIP (Tobramycin inhalation powder)1件: Tobramycin1件: D00063 --1件: 299
1222TIS (Tobramycin Inhalation Solution)1件: Tobramycin1件: D00063 --1件: 299
1223TIS or TIP----1件: 299
1224TMP1件: TMP---1件: 299
1225TNSE----1件: 299
1226TOBI----1件: 299
1227TOBI (tobramycin)1件: Tobramycin1件: D00063 --1件: 299
1228TOBI 300 mg / 5 mL nebuliser solution1件: Tobramycin1件: D00063 --1件: 299
1229TOBI 300 mg/5 ml Lösung für einen1件: Tobramycin1件: D00063 --1件: 299
1230TOBI 300 mg/5 ml Lösung für einen Vernebler1件: Tobramycin1件: D00063 --1件: 299
1231TOBI 300 mg/5 ml Nebuliser Solution1件: Tobramycin1件: D00063 --1件: 299
1232TOBI 300 mg/5 ml solución para inhalación por nebulizador1件: Tobramycin1件: D00063 --1件: 299
1233TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur1件: Tobramycin1件: D00063 --1件: 299
1234TOBI 300mg/ 5ml solución para inhalación con nebulizador1件: Tobramycin1件: D00063 --1件: 299
1235TOBI 300mg/5mL Nebuliser Solution1件: Tobramycin1件: D00063 --1件: 299
1236Tobi 300mg/5ml Nebuliser solution.1件: Tobramycin1件: D00063 --1件: 299
1237Tobi 300mg/5ml Solución para inhalación por nebulizador.1件: Tobramycin1件: D00063 --1件: 299
1238Tobi Inhalant Product1件: Tobramycin1件: D00063 --1件: 299
1239Tobi Nebcinal----1件: 299
1240TOBI PODHALER----1件: 299
1241TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE1件: Tobramycin1件: D00063 --1件: 299
1242TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation1件: Tobramycin1件: D00063 --1件: 299
1243TOBI Podhaler 28 mg inhalációs por, kemény kapszula1件: Tobramycin1件: D00063 --1件: 299
1244TOBI PODHALER*448CPS 28MG+10IN1件: Tobramycin1件: D00063 --1件: 299
1245TOBI*NEBUL 56F 1D 300MG/5ML1件: Tobramycin1件: D00063 --1件: 299
1246TOBI®1件: Tobramycin1件: D00063 --1件: 299
1247TOBI™ Podhaler™ 112 mg inhaled twice daily----1件: 299
1248Tobramcyin----1件: 299
1249TOBRAMICINA1件: Tobramycin1件: D00063 --1件: 299
1250Tobramicina polvere inalatoria1件: Tobramycin1件: D00063 --1件: 299
1251TOBRAMICINA SOLFATO1件: Tobramycin1件: D00063 --1件: 299
1252Tobramicyn----1件: 299
1253TOBRAMYCIN1件: Tobramycin1件: D00063 --1件: 299
1254Tobramycin (Gernebcin®)1件: Tobramycin1件: D00063 --1件: 299
1255Tobramycin / Bramitob1件: Tobramycin1件: D00063 --1件: 299
1256Tobramycin / TOBI1件: Tobramycin1件: D00063 --1件: 299
1257Tobramycin 100 PARI1件: Tobramycin1件: D00063 --1件: 299
1258Tobramycin dry powder1件: Tobramycin1件: D00063 --1件: 299
1259Tobramycin for Inhalation1件: Tobramycin1件: D00063 --1件: 299
1260Tobramycin Inhalation Powder1件: Tobramycin1件: D00063 --1件: 299
1261Tobramycin Inhalation Powder (TIP)1件: Tobramycin1件: D00063 --1件: 299
1262Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler1件: Tobramycin1件: D00063 --1件: 299
1263Tobramycin inhalation solution1件: Tobramycin1件: D00063 --1件: 299
1264Tobramycin Inhalation Solution (TIS)1件: Tobramycin1件: D00063 --1件: 299
1265Tobramycin inhalation solution using a PARI LC® Plus nebulizer.1件: Tobramycin1件: D00063 --1件: 299
1266Tobramycin injection 40mg/1ml1件: Tobramycin1件: D00063 --1件: 299
1267Tobramycin nebulized nasally1件: Tobramycin1件: D00063 --1件: 299
1268Tobramycin Powder1件: Tobramycin1件: D00063 --1件: 299
1269Tobramycin Solution for Inhalation1件: Tobramycin1件: D00063 --1件: 299
1270Tobramycin solution for inhalation (TOBI)1件: Tobramycin1件: D00063 --1件: 299
1271Tobramycin solution for inhalation 300 mg1件: Tobramycin1件: D00063 --1件: 299
1272Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution1件: Tobramycin1件: D00063 --1件: 299
1273TOBRAMYCIN SULFATE2件: Sulfate ion,
Tobramycin		1件: D00063 --1件: 299
1274Tobramycine1件: Tobramycin1件: D00063 --1件: 299
1275Tobramycinum1件: Tobramycin1件: D00063 --1件: 299
1276Tobrineb/Bramitob----1件: 299
1277Tocotrienol1件: Tocotrienol---3件: 21, 156, 299
1278TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML----1件: 299
1279Tozinameran1件: Tozinameran1件: D11971 --1件: 299
1280TR02----1件: 299
1281Tranexamic acid1件: Tranexamic acid1件: D01136 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 70, 215, 227, 274, 288, 299
1282Transdermal estrogen----1件: 299
1283Treatment----2件: 41, 299
1284Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor4件: Elexacaftor,
Ivacaftor,
Lumacaftor,
Tezacaftor		4件: D09916 ,
D10134 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1285Treatment with polyethylene glycol (Macrogol 4000)1件: Polyethylene glycol1件: D03370 --1件: 299
1286Trifakta----1件: 299
1287Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1288Trimethoprim1件: Trimethoprim1件: D00145 --7件: 36, 44, 49, 60, 61, 85, 299
1289Trimethoprim and Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		2件: D00145 ,
D00447 		--1件: 299
1290Trimethoprim Sulfamethoxazole (TMP/SMX)3件: Sulfamethoxazole,
TMP,
Trimethoprim		2件: D00145 ,
D00447 		--1件: 299
1291Trimethoprim-Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		2件: D00145 ,
D00447 		--3件: 49, 61, 299
1292Trimethoprim/Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		2件: D00145 ,
D00447 		--1件: 299
1293Trimethoprim/Sulfamethoxazole (TMP/SMX)3件: Sulfamethoxazole,
TMP,
Trimethoprim		2件: D00145 ,
D00447 		--1件: 299
1294Trimetoprim----1件: 299
1295Triple combination therapy----1件: 299
1296Turmeric1件: Turmeric---4件: 140, 144, 158, 299
1297Ultrase----1件: 299
1298Ultrase® MT12----1件: 299
1299Ultrase® MT20----1件: 299
1300ULTRESA----1件: 299
1301Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)1件: Genistein1件: D11680 --1件: 299
1302Uridine1件: Uridine---1件: 299
1303Urinary levels of PIIINP as a marker of changes in renal function----1件: 299
1304Ursodiol1件: Ursodeoxycholic acid1件: D00734 1件: NR1H4 💬1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299
1305V-Fend----1件: 299
1306Vaccin grippal pandémique H1N1----1件: 299
1307Vaccination with vaccine against hepatitis A and B----1件: 299
1308Valganciclovir1件: Valganciclovir1件: D02495 --4件: 85, 97, 299, 331
1309Valganciclovir [Valcyte]1件: Valganciclovir1件: D02495 --1件: 299
1310Vancomycin1件: Vancomycin1件: D00212 --8件: 13, 46, 70, 94, 96, 97, 296, 299
1311Vancomycin hydrochloride inhalation powder1件: Vancomycin1件: D00212 --1件: 299
1312Vancomycin inhalation powder1件: Vancomycin1件: D00212 --1件: 299
1313Vantobra (tobramycin)1件: Tobramycin1件: D00063 --1件: 299
1314Vardenafil1件: Vardenafil1件: D08668 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬3件: 13, 86, 299
1315Vaxzevria1件: AstraZeneca COVID-19 Vaccine---1件: 299
1316Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S1件: AstraZeneca COVID-19 Vaccine---1件: 299
1317VEDROP1件: Tocofersolan1件: D06174 --1件: 299
1318Ventolin1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1319Ventolin® Evohaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1320Ventolin¿ Evohaler¿1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1321Vfend1件: Voriconazole1件: D00578 --1件: 299
1322VFEND 40 mg/ml powder for oral suspension1件: Voriconazole1件: D00578 --1件: 299
1323Vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--4件: 6, 201, 229, 299
1324Vitamin D1件: Vitamin D---20件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299
1325Vitamin D Oil1件: Vitamin D---1件: 299
1326Vitamin D Powder1件: Vitamin D---1件: 299
1327Vitamin D21件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬3件: 49, 84, 299
1328Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬12件: 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299
1329Vitamin E1件: Vitamin E1件: D02331 --11件: 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317
1330VITAMIN E - TGPS1件: Vitamin E1件: D02331 --1件: 299
1331Vitamin K1件: Phylloquinone---2件: 46, 299
1332Vitamin K supplementation, dose #11件: Phylloquinone---1件: 299
1333Vitamin K supplementation, dose #21件: Phylloquinone---1件: 299
1334Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:11件: Choline1件: D07690 --1件: 299
1335Voriconazole1件: Voriconazole1件: D00578 --2件: 60, 299
1336VR496----1件: 299
1337VRT-813077----1件: 299
1338VRT-826809----1件: 299
1339VRT-893661----1件: 299
1340VRT-893661 VRT-0893661----1件: 299
1341VX-121----1件: 299
1342VX-121/TEZ/D-IVA----1件: 299
1343VX-121/tezacaftor/deutivacaftor2件: Deutivacaftor,
Tezacaftor		2件: D11041 ,
D11423 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1344VX-152----1件: 299
1345VX-371----1件: 299
1346VX-371 in hypertonic saline----1件: 299
1347VX-371 in saline----1件: 299
1348VX-440----1件: 299
1349VX-445----1件: 299
1350VX-445 / TEZ / IVA----1件: 299
1351VX-445 / TEZ / IVA FDC----1件: 299
1352VX-445 /TEZ/IVA----1件: 299
1353VX-445/TEZ/IVA----1件: 299
1354VX-522 mRNA therapy----1件: 299
1355VX-561----1件: 299
1356VX-561 (CTP-656)----1件: 299
1357VX-6591件: VX-659---1件: 299
1358VX-659/ TEZ/IVA1件: VX-659---1件: 299
1359VX-659/TEZ/IVA1件: VX-659---1件: 299
1360VX-659/Tezacaftor/Ivacaftor3件: Ivacaftor,
Tezacaftor,
VX-659		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1361VX-661----1件: 299
1362VX-661 / VX-770----1件: 299
1363VX-661 Plus Ivacaftor Combination1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1364VX-661, VRT-893661----1件: 299
1365VX-661/Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1366VX-661/ivacaftor (VX-770) 100mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1367VX-661/ivacaftor 100 mg/ 150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1368VX-661/ivacaftor 100mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1369VX-661/ivacaftor 100mg/150mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1370VX-661/ivacaftor 50 mg/ 75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1371VX-661/VX-770----1件: 299
1372VX-661/VX-770 (TEZ/IVA)----1件: 299
1373VX-77----1件: 299
1374VX-770----1件: 299
1375VX-770, VRT-8130077----1件: 299
1376VX-770, VRT-813077----1件: 299
1377VX-809----1件: 299
1378VX-809 & VX-770----1件: 299
1379VX-809 / VX-770----1件: 299
1380VX-809, VRT-826809----1件: 299
1381VX-809/VX-770----1件: 299
1382Water1件: Water1件: D00001 --21件: 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299
1383Water for injections1件: Water1件: D00001 --1件: 299
1384WATER FOR INJECTIONS, EP1件: Water1件: D00001 --1件: 299
1385WRAIR_PAM-CF1----1件: 299
1386Xenon1件: Xenon2件: D01901 ,
D06339 		--3件: 22, 85, 299
1387Xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
1388Xolair1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬2件: 46, 299
1389Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299
1390Xylitol1件: Xylitol1件: D00061 --2件: 53, 299
1391Zadaxin----2件: 65, 299
1392ZAVESCA1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
1393Zenpep----2件: 298, 299
1394Zinc1件: Zinc---3件: 2, 171, 299
1395Zinc acetate2件: Acetate,
Zinc acetate		1件: D06408 --2件: 171, 299
1396Zinc acetate (20mg/d)3件: Acetate,
Zinc,
Zinc acetate		1件: D06408 --1件: 299
1397ZITHOMAX 40 mg/ml ENFANTS----1件: 299
1398Zithromax1件: Azithromycin2件: D06390 ,
D07486 		--2件: 228, 299
1399ZITHROMAX 250 mg1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
1400Zitromax----2件: 228, 299
1401Zn----2件: 113, 299
1402Zoledronic acid1件: Zoledronic acid2件: D01968 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬12件: 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333